Two recent studies looked at changes in colorectal cancer (CRC) incidence over time, one in U.S. adults ages 40 to 49 years and one in European adults ages 20 to 49 years.
The increase primarily occurred among people who reported drug use or homelessness.
There was no significant difference in upper GI events between a pantoprazole group and a placebo group, although pantoprazole was associated with significantly reduced bleeding of gastroduodenal lesions, an industry-funded study found.
Highlights from the conference, held this past week in San Diego, included new research and clinical tips on stopping Barrett's esophagus surveillance, diet and environmental risk factors in patients with inflammatory bowel disease, and new research on proton-pump inhibitors.
An editorial noted that referrals to screening could be handled by other clinic staff, easing the burden on physicians.